Gel Tech
This article was originally published in The Tan Sheet
Executive Summary
Zicam marketer to pay Quigley $1.1 mil. and 5.5% royalty on cold remedy sales from April 1, 2000 to March 5, 2002, with minimum royalty payment of $500,000, under settlement of Cold-Eeze zinc lozenges marketer's patent infringement lawsuit on fourth day of trial in Philadelphia federal court June 7. Quigley sued Gel Tech in November 1999, alleging Zicam homeopathic zinc nasal spray infringed its '465 patent covering application of zinc gluconate to virus-infected tissue to reduce duration of common cold
Zicam marketer to pay Quigley $1.1 mil. and 5.5% royalty on cold remedy sales from April 1, 2000 to March 5, 2002, with minimum royalty payment of $500,000, under settlement of Cold-Eeze zinc lozenges marketer's patent infringement lawsuit on fourth day of trial in Philadelphia federal court June 7. Quigley sued Gel Tech in November 1999, alleging Zicam homeopathic zinc nasal spray infringed its '465 patent covering application of zinc gluconate to virus-infected tissue to reduce duration of common cold. |